Agilent Technologies (NYSE:A – Get Free Report) updated its FY 2026 earnings guidance on Wednesday. The company provided EPS guidance of 6.000-6.100 for the period, compared to the consensus EPS estimate of 5.970. The company issued revenue guidance of $7.4 billion-$7.5 billion, compared to the consensus revenue estimate of $7.4 billion. Agilent Technologies also updated its Q3 2026 guidance to 1.480-1.500 EPS.
Analyst Ratings Changes
A has been the topic of several research analyst reports. Barclays reduced their price objective on shares of Agilent Technologies from $150.00 to $140.00 and set an “overweight” rating on the stock in a report on Tuesday, April 14th. Robert W. Baird upped their target price on shares of Agilent Technologies from $155.00 to $156.00 and gave the stock an “outperform” rating in a research note on Tuesday. TD Cowen dropped their price objective on shares of Agilent Technologies from $170.00 to $157.00 and set a “buy” rating on the stock in a research report on Thursday, February 26th. UBS Group cut their price objective on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a report on Thursday, February 26th. Finally, Wall Street Zen cut Agilent Technologies from a “buy” rating to a “hold” rating in a research report on Saturday, May 9th. Two research analysts have rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Buy” and an average target price of $162.40.
Check Out Our Latest Research Report on Agilent Technologies
Agilent Technologies Stock Performance
Agilent Technologies (NYSE:A – Get Free Report) last posted its quarterly earnings data on Wednesday, February 25th. The medical research company reported $1.36 earnings per share for the quarter, missing analysts’ consensus estimates of $1.37 by ($0.01). Agilent Technologies had a net margin of 18.26% and a return on equity of 24.49%. The firm had revenue of $1.80 billion during the quarter, compared to analysts’ expectations of $1.81 billion. During the same quarter last year, the business earned $1.31 earnings per share. The business’s quarterly revenue was up 7.0% on a year-over-year basis. On average, equities analysts expect that Agilent Technologies will post 5.95 EPS for the current year.
Agilent Technologies Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 22nd. Investors of record on Tuesday, June 30th will be paid a $0.255 dividend. The ex-dividend date is Tuesday, June 30th. This represents a $1.02 annualized dividend and a dividend yield of 0.9%. Agilent Technologies’s dividend payout ratio (DPR) is 22.52%.
Institutional Trading of Agilent Technologies
Hedge funds and other institutional investors have recently made changes to their positions in the stock. State of Wyoming purchased a new stake in shares of Agilent Technologies in the 2nd quarter worth about $35,000. Transamerica Financial Advisors LLC increased its position in Agilent Technologies by 180.8% during the 4th quarter. Transamerica Financial Advisors LLC now owns 337 shares of the medical research company’s stock worth $46,000 after purchasing an additional 217 shares in the last quarter. Johnson Financial Group Inc. acquired a new stake in Agilent Technologies during the 3rd quarter worth approximately $49,000. DV Equities LLC acquired a new stake in Agilent Technologies during the 4th quarter worth approximately $54,000. Finally, Itau Unibanco Holding S.A. acquired a new position in Agilent Technologies during the fourth quarter valued at approximately $58,000. Institutional investors and hedge funds own 87.41% of the company’s stock.
About Agilent Technologies
Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.
Founded as a corporate spin-off from Hewlett?Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.
Featured Stories
- Five stocks we like better than Agilent Technologies
- Abercrombie Rallies as Strong Q1 Earnings Extend Winning Streak
- TeraWulf Bets on Power Infrastructure to Lead AI Build-Out
- Amazon’s Alexa for Shopping Strengthens an Already Strong Bull Case
- Keysight: The AI and Defense Stock Seeing Big Price Target Boosts
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
